(2-Chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid

Catalog No. :
ACOIPA791
CAS No. :
1449131-93-4
Molecular Formula :
C11H13BClNO3
Molecular Weight :
253.49

IUPAC Name:(2-chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid

(2-Chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$635.00Login to see priceInquiryInquiry
1g98%$954.00Login to see priceInquiryInquiry
5g98%$3152.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid
IUPAC Name(2-chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid
MDL No.MFCD22125137
Molecular FormulaC11H13BClNO3
Molecular Weight253.49
SMILESOB(C1=CC=C(C(N2CCCC2)=O)C=C1Cl)O
InChI KeyCCPHBMWIZPSWRQ-UHFFFAOYSA-N
Synonym2-Chloro-4-(1-pyrrolidinylcarbonyl)phenylboronic acid;Boronic acid, B-[2-chloro-4-(1-pyrrolidinylcarbonyl)phenyl]-;(2-Chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid
CAS No.1449131-93-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOIPA791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEPYG432 route compound structure diagram
    ACEPYG432851335-09-6 In Stock
  4. Then
  5. ACOIPA791 route product structure diagram
    ACOIPA7911449131-93-4
Inquiry

2. ACOIPA791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOIPA791 route product structure diagram
    ACOIPA7911449131-93-4
Inquiry

Comments (0)